HMG and OncoCare Sign "Pan-Asian Strategic Cooperation Agreement" Joining Forces to Build a "Pan-Asian Closed-Loop Medical Ecosystem" to Provide One-Stop, Full-Cycle Care for Cross-Border Cancer Patients

Traitements contre le cancer : «La Chine est en train de devenir le leader mondial du médicament»

LG Chem Partners with Chinese Biotech to Develop Cancer Drugs

China creates new regulatory pathway to accelerate access to advanced biomedical therapies

China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and

Daegu Health College Showcases Digital Healthcare Achievements at MEDeXPO Korea

LG Chem partners with China's OTR to develop cancer drugs

Childhood cancer control in Asia: challenges and opportunities in paediatric oncology

This Series published in The Lancet Child & Adolescent Health and eClinicalMedicine examines the challenges and opportunities for childhood